ムラグリタザル
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
ムラグリタザル 価格
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
ムラグリタザル 化学特性,用途語,生産方法
効能
糖尿病治療薬, 脂質異常症治療薬, ペルオキシソーム増殖因子活性化受容体(PPAR)作動薬
説明
Muraglitazar is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ (EC
50s = 0.32 and 0.11 μM, respectively). It is selective for PPARα/γ over other nuclear receptors, including PPARδ, RXRα, RARs, estrogen receptor α (ERα), ERβ, androgen receptor (AR), and progesterone receptor (PR). Muraglitazar (50 μM) reduces the size of lipid droplets in oleic acid-treated HepaRG human hepatocytes. It reduces plasma levels of glucose, triglycerides, free fatty acids, and insulin by 54, 33, 62, and 48%, respectively, in
db/db mice when administered at a dose of 10 mg/kg per day. Muraglitazar (10 mg/kg per day) reduces plasma levels of glucose, triglycerides, and cholesterol in diet-induced obese mice. Muraglitazar also inhibits LPS-induced increases in nitric oxide (NO) production and IL-6, TNF-α, and inducible nitric oxide synthase (iNOS) protein levels in J774 murine macrophages in a concentration-dependent manner. It inhibits carrageenan-induced paw edema in mice when administered at doses ranging from 12.5 to 50 mg/kg.
化学的特性
Off-White Solid
使用
It is a peroxisome proliferator-activated receptor (PPAR) a/ dual agonist
ムラグリタザル 上流と下流の製品情報
原材料
準備製品
ムラグリタザル 生産企業
Global( 49)Suppliers
331741-94-7(ムラグリタザル)キーワード:
- 331741-94-7
- N-[(4-Methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine
- Pargluva
- 2-(((4-Methoxyphenoxy)carbonyl)(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)aMino)acetic acid
- 2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-y l)ethoxy]phenyl]methyl]amino]acetic acid
- BMS 298585
- Muraglitazar
- Amylin (8-37), amide
- AMYLIN (8-37), AMIDE; AMYLIN PHARMACEUTICALS; MURAGLITAZAR; OXYNTOMODULIN; SYMLINDIABETES ASSOCIATED PEPTIDE (8-37), AMIDE
- amylin pharmaceuticals
- symlinDiabetes Associated Peptide (8-37), amide
- Glycine, N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]-
- muraglitazar(BMS-298585)
- N-((4-Methoxyphenoxy)carbonyl)-N-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)glycine
- ムラグリタザル
- N-(4-メトキシフェノキシカルボニル)-N-[4-[2-(2-フェニル-5-メチル-4-オキサゾリル)エトキシ]ベンジル]グリシン
- 4-[2-(2-フェニル-5-メチルオキサゾール-4-イル)エトキシ]ベンジル(4-メトキシフェノキシカルボニル)アミノ酢酸
- 2-{[(4-メトキシフェノキシ)カルボニル]({4-[2-(5-メチル-2-フェニル-1,3-オキサゾール-4-イル)エトキシ]フェニル}メチル)アミノ}酢酸